2021 US Regulatory Outlook: Watch For What FDA Does With EUAs – And More
What the agency will do with emergency use authorizations will be just one hot topic this year, experts say
In a podcast interview with Medtech Insight, Hogan Lovells attorneys Mike Heyl and Jodi Scott predict what to expect this year when it comes to US regulation and policy matters.
You may also be interested in...
The document from the Medical Device Innovation Consortium aggregates external data sources, various statistical methods and lays out other considerations for sponsors to help speed up and bolster a premarket product application to the US FDA.
A top executive at the Swedish company spoke with Medtech Insight about how the mobility and data reliability of 5G cellular technology will change how medtech manufacturers design their products.
The US FDA is waiving premarket notification requirements for coagulation systems to monitor COVID-19 patients who are at high risk for blood clotting.